View Clause Headings                                                                                                                                               HelpHelp
DOCUMENT TITLE:  COLLABORATION AGREEMENT BY AND BETWEEN PHARMACYCLICS, INC., AND LES LABORATOIRES SERVIER AND INSTITUT DE RECHERCHES INTERNATIONALES SERVIER .
ACTIONS: Here are the clause headings in the document. To view the clause, click the clause heading.To view the full document, click the "View Document" button.

View Document Back
Clause Heading
ARTICLE 1 - DEFINITIONS
ARTICLE 2 - MANAGEMENT OF THE COLLABORATION
2.1.1 - Formation and Purpose.
2.1.2 - Meetings.
2.1.3 - Specific Responsibilities of the JDRC.
3.1 - Scope of Research
3.2.1 - Option Exercise.
3.2.2 - License Negotiation.
3.2.3 - Option Compound Return.
3.3 - Personnel and Resources.
3.4 - Term of the Research Program
3.5 - Expenses
3.6 - Exclusivity
4.1.1 - Servier Obligations.
4.1.2 - Development Plan.
4.1.3 - Change in Formulation.
4.2 - Exchange of Data.
4.4 - Regulatory Submissions
4.8 - Regulatory Inspections.
4.5 - Commercialization
4.7 - Reports; Inspection
4.9 - Audit Rights
4.10 - Failure to Develop or Register or Commercialize
5.1 - License Fee
5.2 - Research Funding
5.3 - Milestone Payments.
5.4 - Royalties
5.4.1 - Royalty Payments and Reports.
5.4.2 - Non-Monetary Consideration.
5.4.3 - Records and Audit.
5.5 - Taxes and Withholding
5.6 - Currency
5.7 - Blocked Currency
5.8 - Payments; Late Payments
6.1.1 - Development, Manufacture and Commercialization License to Servier.
6.1.2 - Non-exclusive License to Pharmacyclics Biomarkers.
6.1.3 - Development and Commercialization License to Pharmacyclics.
6.1.4 - Third Party Technology.
6.2.1 - Competitive Compounds.
6.3 - No Other Rights and Retained Rights
6.4 - General Communications.
7.1.1 - Pharmacyclics Ownership.
7.1.2 - Servier Ownership.
7.1.3 - Joint ownership
7.1.4 - Inventorship.
7.2 - Ownership of Approval Applications And Regulatory Approvals
7.3 - Disclosure
7.4.1 - Existing Patents.
7.4.2 - Patent Applications for Inventions
(i) - Proposal.
(ii) - Responsibility.
7.5 - Enforcement of Patent Rights
7.5.1 - Notice.
7.5.2 - Enforcement of Pharmacyclics Patent Rights.
7.5.3 - Enforcement of Servier Patent Rights and Joint Patents.
7.5.4 - Recoveries.
7.6 - Infringement Of Third Party Rights.
7.7 - Settlement With A Third Party
7.8.1 - Ownership.
7.8.2 - Notice of Unauthorized Use.
8.1 - Confidentiality; Exceptions
8.2 - Authorized Disclosure
8.3 - Confidential Terms.
8.4 - Return of Confidential Information
8.5 - Publication of Product Information.
9.1 - Representations and Warranties of the Parties Concerning Corporate Authorizations
9.2 - Representations, Warranties and Covenants of Pharmacyclics
9.3 - Representations, Warranties and Covenants of Servier
9.4 - Disclaimer
10.1 - Indemnification by Servier
10.2 - Indemnification By Pharmacyclics
10.3.1 - Servier Responsibilities.
10.3.2 - Pharmacyclics Responsibilities.
10.4 - Limitation of Liability; Exclusive Remedies
10.4.1 - Limitation of Liability.
10.4.2 - Remedies.
11.1.1 - Expiration.
11.3 - Termination for Cause
11.6.3 - Return of Materials.
11.4 - Termination for Insolvency
11.5 - Termination at will
11.6 - Rights on Termination
11.6.4 - Licenses to Data, Confidential Information and Trademarks.
11.7 - Accrued Rights
11.8 - No Renewal, Extension or Waiver.
11.9 - Survival
12.1 - Governing Law
12.2 - Dispute Resolution
13.1 - Assignment
13.2 - Force Majeure
13.3 - Further Actions
13.4 - Governmental Approvals; Compliance With Law
13.5.1 - Initial Release.
13.5.2 - Further Publicity.
13.6 - Notices
13.7 - Waiver
13.8 - Disclaimer Of Agency
13.9 - Ambiguities
13.10 - Headings and Section References
13.11 - Severability
13.12 - Maintenance of Records
13.14 - Entire Agreement
13.15 - Use of Names
13.13 - Standstill
13.6 - Counterparts